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We have investigated the action of hydrocortisosone onarachidonic acid mobilisation i cultures of mouse 
peritoneal macrophages, mouse L,,,cells and the mouse macrophage-like cell line RAW,@. Hydrocortisone 
inhibits both arachidonic acid release and prostaglandin production by L9?9 cells. However, prostaglandin 
production by macrophages or RAW,,cells is inhibited with a concomitant s imulation rather than inhibi- 
tion of arachidonic acid release. These data suggest that hydrocortisone acts at the level of phospholipase 
activity in fibroblasts but at a later stage of prostanoid production i macrophages. 
Glucocorticoid steroid Macrophage Prostaglandin 
1. INTRODUCTION 
The anti-inflammatory action of glucocorticoid 
steroids has been attributed to their ability to in- 
hibit prostaglandin and leukotriene synthesis [ 11. 
These inflammatory mediators are derived from 
arachidonic acid, which is stored in lipid body and 
membrane phospholipids [2] and released by 
phospholipases AZ and C [3]. Evidence has been 
presented that steroids exert their inhibitory action 
at the level of phospholipase activity, firstly 
because exogenous arachidonic acid can overcome 
steroid inhibition of prostanoid synthesis, and 
secondly because arachidonic acid release from 
fibroblasts is inhibited by steroids to the same ex- 
tent as prostanoid production [4]. We show here, 
however, that prostaglandin Ez (PGE2j production 
by resting mouse peritoneal macrophages is in- 
hibited by hydrocortisone, with a concomitant 
stimulation rather than reduction in arachidonic 
acid release. Because macrophages are the major 
source of eicosanoid products amongst leucocytes 
[5], our observations uggest that a locus of steroid 
inhibition other than phospholipase activity may 
play an important role in the anti-inflammatory 
actions of glucocorticoid hormones. 
Arachidonic acid metabolism was studied in 
BALB/c resting peritoneal macrophages after 24 h 
in culture [6] and in the macrophage-like virally 
transformed RAW264 [7] cell line as well as the 
mouse L929 fibroblast line [8]. By pre-labelling C&S 
with [14C]arachidonic acid, the effect of hydrocor- 
tisone on both total arachidonic acid derived 
metabolite release, and on individual eicosanoid 
products, identified by thin-layer chromatography 
(TLC), could be investigated [9] (fig.7, [6]). In ad- 
dition, PGEz production was measured by 
radioimmunoassay [lo] using a variety of different 
stimuli to induce arachidonic acid mobilisation in 
the presence and absence of hydrocortisone. 
2. MATERIALS AND METHODS 
Macrophages from female BALB/c mice, killed 
by CO2 inhalation, were prepared by peritoneal 
lavage with RPM1 1640, containing 10% foetal 
calf serum (FCS) (Flow) and penicillin (100 
units/ml) and streptomycin (100 pg/mlj. Cells 
were plated into 24 well plates (Linbroj at a density 
of 2.5 x 10’ macrophages per well in a 5% CO2 
humidified incubator at 37°C. After 90 min, non- 
adherent cells were removed by washing in the 
Published by Elsewer Science Publishers B. V. 
00145793/84/$3.00 0 1984 Federation of European Biochemical Societies 143 
Volume 174, number 1 FEBS LETTERS August 1984 
same medium. Experiments were carried out 24 h 
later. Lg29 cells were grown in the same medium at 
an initial density of about lo6 cells per well. Both 
macrophages and L929 cells were labelled for 2 h 
with [14C]arachidonic acid (Amersham; 60 mCi/ 
mM, 0.2 &i/ml, 0.5 ml per well). After 5 washes 
with serum-free RPMI, test stimuli [6] were added 
to duplicate or triplicate cultures (0.5 ml/well). 
RAW264 cells were treated exactly as were the Lg29 
cells. Arachidonic acid release was induced with 
10% FCS, 0.2% sheep red blood cell (SRBC) sen- 
sitised with 100 pug/ml IgG2b Sp2 monoclonal anti- 
body (Seralab), zymosan (Sigma), calcium iono- 
phore A23187 (Sigma) or ATP (Sigma) dissolved 
in RPM1 1640 containing antibiotics. Hydrocor- 
tisone hemisuccinate (Sigma) was freshly prepared 
and used at a final concentration of 2.5 pg/ml. At 
various times, supernatants were sampled, micro- 
fuged (1 min, 5000 x g) and counted (25 ~1) in PCS 
scintillant (Amersham). 
Radiolabelled products were also analysed by 
TLC. Total supernatants were extracted and 
analysed after 2- 18 h stimulation [9], using What- 
man LKSD silica plates in a solvent system of ethyl 
acetate : 2,2,4_trimethylpentane : acetic acid : water 
(110 :50 : 20 : 100, v/v) and then autoradiographed 
at -70°C using Kodak X-Omat film for 1-14 
days. Identity of labelled products was decided by 
comparison with authentic prostaglandin and 
arachidonic acid markers. Quantitation of pro- 
ducts was carried out by carefully cutting out strips 
corresponding to identified bands after autoradio- 
graphy, and counting them in PCS scintillant. 
Radioimmunoassays of PGE2 [lo] were carried 
out on unlabelled macrophages or mouse Lg2g cells 
plated at similar densities to those used above, into 
quadruplicate wells of 48 well plates (Costar), after 
2-18 h stimulation. 
3. RESULTS AND DISCUSSION 
In neither primary macrophage cultures nor 
RAW264 cells could we detect a steroid-induced in- 
hibition of total r4C metabolite release (fig.1) or a 
reduction in r4C-labelled arachidonic acid release, 
quantified after TLC. Nonetheless, PGE2 produc- 
tion by primary macrophages, measured by 
radioimmunoassay or after TLC, and PGD2 pro- 
duction by RAW264 cells measured after TLC, 
were inhibited (30-65%) by hydrocortisone (table 
144 
1) (PGD2 is the major prostanoid released by 
stimulated RAW264 cells). In contrast, both 
arachidonic acid release and PGE2 production by 
mouse L929 cells were inhibited by hydrocortisone 
(fig.1, table 1) in agreement with the original 
observations on mouse MC5-5 cells [4]. 
Because total 14C counts released from 
macrophages or RAW264 cells are unaffected, or 
even stimulated by hydrocortisone treatment, 
whilst prostaglandin levels are reduced, arachi- 
donic acid must either be diverted to other eicosa- 
noid products, or be present at higher levels in the 
supernatants of steroid-treated cells. Higher levels 
of [14C]arachidonic acid, quantitated after TLC, 
are indeed present in steroid-treated macrophage 
and RAW264 supernatants, concomitant with the 
reduction in prostaglandin levels [e.g., with hydro- 
cortisone (2.5 pg/ml) after 18 h incubation with 
10% FCS; macrophage PGE2 production down 
29%, arachidonic acid release up 57%]. This im- 
plies that the locus of hydrocortisone inhibition 
lies after the phospholipase-catalysed release of 
arachidonic acid, and before or during its conver- 
sion by cyclooxygenase or lipoxygenases. Such a 
side of inhibition is compatible with the ability of 
exogenous arachidonic acid to stimulate PGE2 pro- 
duction in steroid-treated cells, particularly as it is 
still possible to observe an inhibitory effect of 
steroid on exogenous arachidonic acid conversion 
([4], fig.3, unpublished). 
Mast cell arachidonic acid release is also refrac- 
tory to steroid inhibition, except when induced by 
IgE-mediated stimulation [l 11. We have demon- 
strated a lowering of Fc y 2b receptor expression 
on steroid-treated macrophages [6] which results in 
reduced prostanoid production when cells are 
stimulated with IgGZt, immune complexes. An 
analogous mechanism could explain the selec- 
tive steroid inhibition of IgE-mediated arachidonic 
acid release in the mast cell. Although a steroid- 
induced inhibition of arachidonic acid release has 
been detected in polymorphonuclear cells [14] 
(PMNs) others have failed to detect any inhibition 
of prostaglandin synthesis [121, whilst the stimula- 
tion of lipoxygenase products by N-formyl-Met- 
Leu-Phe has been shown to be independent of 
phospholipase activity in these cells [13]. The 
variable effects of glucocorticoid steroids on pro- 
staglandin synthesis and arachidonic acid release in 
various cell types are summarised in table 2. These 
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Fig. 1. Time course of [‘4C]arachidonic acid metabolite release from mouse peritoneal macrophages (A-C,F) and mouse 
L929 cells (D,F). Arachidonic acid release was stimulated by 10% FCS (A,D), 0.2% (SRBC)-Ig&, immune complex 
[6] (B,E), zymosan (lOO,~g/ml) (C), or calcium ionophore A23187 (F) at 2.5 pg/ml. Similar results were obtained after 
short (2 h) or long (18 h) labelling times, and macrophages and RAW 262 cells showed an identical lack of inhibition 
by hydrocortisone to all stimuli tested. (0) Control, (0) with 2.5 pg/ml hydrocortisone. 
observations suggest that anti-inflammatory exclude the possibility that macrophages 
steroid action is cell-type dependent. We have used manipulated in a different way, for example, 
unstimulated mouse peritoneal macrophages after thioglycolate induced, may behave differently. 
24 h in culture for our experiments, and we cannot Nonetheless, the use of defined populations of 
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Table 1 
Effect of hydrocortisone on macrophage and Lg29 cell PGEz production and arachidonic acid metabolite release 
Stimulus PGEz 
(r&ml) 
+HC % % change 
inhibition [14C]arachidonic acid 
metabolite release 
RPM1 1640 (control) 
Zymosan (100 pg/ml) 
FCS (10%) 
0.2% IgGzt, immune complex 
ATP (1 mM) 
A23 187 (5 pg/ml) 
10% FCS on mouse Lg29 cells 
10% FCS on RAW2b4 cells - PGD2 
production (TLC) 
1.9 0.8 58 + 1.7 
51.2 35.4 32 +3.7 
107.3 52.8 51 + 1.8 
31 13.8 55 0 
6.4 2.3 65 +8 
3.7 3.5 6 + 13 
9.8 6.5 33 -38 
- 42 +6 
Table 2 
Hydrocortisone effects on different cell types 
Cells Arachidonic acid Prostaglandin 
release synthesis 
Fibroblasts [4] 2 1 
Mast cells 1111 -/l 1 
Macrophages T 1 
PMN [12-141 1 - 
I, inhibition; - , no effect; 7, stimulation 
macrophages and the RAW264 line provide a useful 
system for the analysis of this novel locus of anti- 
inflammatory steroid action. 
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